Related Experiment Videos
[Metastases to cervical nodes from unknown primary tumor]
J Kuczkowski1, W Ozdziński, C Stankiewicz
1Katedra i Klinika Chorób Uszu, Nosa, Gardła i Krtani AM w Gdańsku.
Abstract:
The authors presented clinical analysis of 19 patients with cervical nodes metastases from an unknown primary site, treated in Department of Otolaryngology Medical University of Gdańsk in the period from 1981 to 1998. As the primary site of cancer was not found, basing on histopathological and clinical examination 4 patients underwent surgical treatment and in 15 patients combined therapy was applied. In two cases primary tumor was found in lung and trachea after a four months of treatment initiation. Treatment failure was observed in 12 cases, 7 patients survived, 2 of them over 4 years.
Insights
This study analyzed 19 patients with unknown primary head and neck cancers. Treatment outcomes varied, with some patients surviving long-term despite initial challenges in identifying the primary tumor.
Area of Science:
- Oncology
- Otolaryngology
- Clinical Medicine
Context:
- Analysis of 19 patients with cervical lymph node metastases from an unknown primary tumor.
- Treatment provided at the Department of Otolaryngology, Medical University of Gdańsk (1981-1998).
- Focus on histopathological and clinical examination for primary site identification.
Purpose:
- To present a clinical analysis of patients with unknown primary head and neck cancers.
- Evaluate treatment strategies and outcomes for this challenging patient group.
- Identify potential primary sites retrospectively.
Summary:
- 19 patients with metastatic cervical nodes, unknown primary site, were analyzed.
- 4 patients received surgical treatment; 15 received combined therapy.
- Primary tumors (lung, trachea) were identified in 2 cases post-treatment initiation.
- Treatment failure occurred in 12 cases; 7 patients survived, 2 long-term (>4 years).
Impact:
- Highlights the diagnostic and therapeutic challenges in managing unknown primary head and neck cancers.
- Provides insights into treatment efficacy and survival rates for this patient cohort.
- Informs clinical decision-making for similar cases in otolaryngology and oncology.